oxycotin maker purdue pharma is exploring chapter 11 bankruptcy protection as it faces  2000 lawsuits for alleged contributions to the us opioid epidemic .  chapter 11 bankruptcy would allow the company to halt the lawsuits and address its legal challenges under the supervision of a bankruptcy judge . 
